Targeted Protein Degradation Market Size Worth USD 2216.13 Million by 2032 Fueled by the Potential to Treat “Undruggable” Diseases – SNS Insider Read more
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva® Read more
Nanox Engages with Althea France to Accelerate European Commercialization of Nanox.ARC System Read more
Audio Interface Market Size to Surpass USD 367.83 Million by 2033 | Research by SNS Insider Read more
Ready to Drink Beverages Market Driven by Asia Pacific, with Natural and Organic Beverages Projected for 5.75% CAGR to 2030, Reports Mordor Intelligence Read more
BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025 Read more
Jayud Global Logistics Assumes Controlling Interest in Longgang Cross-Border E-Commerce Center Read more